A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection

Rapid Communications in Mass Spectrometry
2004.0

Abstract

<jats:title>Abstract</jats:title><jats:p>Oxidized nucleosides are biochemical markers for tumors, aging, and neurodegenerative diseases. However, during the last decade, the analytical methods for nucleosides by gas chromatography/mass spectrometry (GC/MS) and high‐performance liquid chromatography (HPLC) with single‐parameter detectors like electron‐capture detection (ECD) have not been sufficiently rapid or reliable to detect nucleosides in urine and to analyze clinical samples. It has been reported (Dudley <jats:italic>et al., Rapid Commun Mass Spectrom</jats:italic>. 2000; 14: 1200) that liquid chromatography with electrospray mass spectrometry (LC/ESI‐MS) is more specific and sensitive for analysis of nucleosides than HPLC with conventional detectors; however, this method required complex extraction steps. In the present work a direct LC/ESI‐MS method for nucleosides without extraction of urine samples has been developed. Analysis of nucleosides using positive‐ion mode with selected reaction monitoring effectively eliminated potential interferences from endogenous constituents of the urine. This highly selective and sensitive method made it possible to analyze urinary nucleosides with a lower limit of quantitation of 0.2 nmol/mL. The method has been validated, with both excellent linearity and reproducibility, in the calibration range from 0.2–400 nmol/mL. The correlation coefficients of the calibration curves were higher than 0.987. The coefficients of variation were in the range 0.03–14.92% (inter‐day) and 0.54–14.39% (intra‐day), respectively. Copyright © 2004 John Wiley &amp; Sons, Ltd.

Knowledge Graph

Similar Paper

A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection
Rapid Communications in Mass Spectrometry 2004.0
Quantitation of urinary nucleosides by high-performance liquid chromatography
Journal of Chromatography A 1997.0
Measurement of endogenous uracil and dihydrouracil in plasma and urine of normal subjects by liquid chromatography–tandem mass spectrometry
Journal of Chromatography B 2002.0
Application of solid phase extraction and high-performance liquid chromatography to qualitative and quantitative analysis of nucleotides and nucleosides in human cerebrospinal fluid
Journal of Chromatography B 2005.0
Quantification of urinary o,o′-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometryA comparison with ion-trap tandem mass spectrometry
Journal of Chromatography B 2005.0
Hydrophilic interaction ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry for determination of nucleotides, nucleosides and nucleobases in Ziziphus plants
Journal of Chromatography A 2013.0
Clinical significance and prognostic value of urinary nucleosides in breast cancer patients
Clinical Biochemistry 2005.0
Isocratic high-performance liquid chromatographic method for studying the metabolism of blood plasma pyrimidine nucleosides and bases: concentration and radioactivity measurements
Journal of Chromatography B: Biomedical Sciences and Applications 1988.0
High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma
Journal of Chromatography B 2003.0
Isolation and quantification by high-performance liquid chromatography–ion-trap mass spectrometry of androgen sulfoconjugates in human urine
Journal of Chromatography A 2008.0